The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $107,238.60 firm fixed price purchase order to Quanterix Corporation, a for-profit manufacturer, for Simoa 4-plex 96-well plate assays to quantify serum/plasma biomarkers for Alzheimer's disease research. The assays will be used to analyze samples from participants in the Baltimore Longitudinal Study of Aging and the Genetic and Epigenetic Signatures of Translational Aging Laboratory...
This is a $119,614.50 firm-fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Institute on Aging to Quanterix Corporation, a life sciences company that provides ultra-sensitive digital biomarker detection technology. The award is for Quanterix's Simoa 4-plex and Singleplex 96-well Plate Assays, including reagents, buffers, and shipping, to support the NIH's biomedical research programs. This is an unset-aside, commercial...
This is a purchase order awarded by the National Institutes of Health (NIH) National Institute on Aging to Quanterix Corporation, a for-profit life sciences company, for the delivery of Simoa 4-plex assay kits and related materials. The order is valued at $39,428.06 and is for the supply of Neurology 4-Plex E assay kits, Simoa disk kits, and buffer solutions to process tau protein (p-tau 181) assays for the Baltimore Longitudinal Study of Aging (BLSA). The order does not have a set-aside...
This non-competitive purchase order for $197,979.19 was awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Aging to Quanterix Corporation of Billerica, Massachusetts. The firm fixed price order is for the purchase of Quanterix assay kits including the Neurology 3-Plex A Advantage Kit, pTau-181 Advantage Kit, P-Tau 231 Simoa Assay Kit, discs, buffers, and sealing oil to be used with the Simoa HD-X Analyzer currently owned by NIA. The...
The Department of Health and Human Services, National Institutes of Health awarded a firm fixed price purchase order to Quanterix Corporation, a for-profit manufacturer of goods, for the N4PA SIMOA 2.0 ASSAY KIT. The $112,969.08 award, with an October 2020 completion date, was not set aside. Quanterix has received over $30 million in prior federal contracts from agencies like the NIH, Department of Veterans Affairs, and Department of Defense to supply its ultra-sensitive digital biomarker...
This firm fixed-price purchase order was awarded by the National Institute on Aging, a civilian agency, to Quanterix Corporation for an assay kit to quantify serum/plasma levels of Abeta40, Abeta 42, GFAP, and NF-light using a Simoa 4-plex assay. The $176,152.50 contract supports research on cognitive resilience and impairment, including for Alzheimer's disease, under the Baltimore Longitudinal Study of Aging. This requirement did not utilize any set-asides. Quanterix, a for-profit manufacturer,...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations to Quanterix Corporation, a life sciences company that provides ultra-sensitive digital biomarker detection technology. The contract, valued at $100,500.00, is for custom assay development services. Quanterix has received over $30 million in prior federal contracts from agencies including the National Institutes of Health,...
This is a $19,170.11 firm-fixed-price purchase order contract awarded by the National Institute of Nursing Research, a civilian agency, to Quanterix Corporation, a life sciences company specializing in ultra-sensitive digital biomarker detection technology. The contract is for the provision of Quanterix's Simoa (single molecule array) instruments, assay kits, and research services, which enable the measurement of proteins and other biomarkers at unprecedented levels of sensitivity. This supports...
This is a firm fixed-price service contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Quanterix Corporation, a for-profit manufacturer of digital biomarker analysis technology. The contract, valued at $15,000.00, is for Quanterix to provide Simoa detection platform instruments, assay kits, reagents, and maintenance services to support NIH research on diseases such as Alzheimer's, post-traumatic stress disorder, and infectious...
This contract was awarded by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute on Drug Abuse to Quanterix Corporation, a life sciences company that provides ultra-sensitive digital biomarker detection technology. The $149,000 firm-fixed-price purchase order is to analyze 9 human biomarkers from 1,122 samples. This work supports the NIH's research examining the relationship between inflammation and aging. Quanterix has been awarded over $30...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Institute on Aging to Quanterix Corporation, a for-profit manufacturer, for the purchase of Simoa 4-plex 96-well plate assays. The assays will be used to investigate biomarkers related to Alzheimer's disease as part of the Baltimore Longitudinal Study of Aging. The potential value of the award is $197,969.40, and the completion date is December 20, 2021. This award is not associated with a set-aside program. Quanterix Corporation has received over $30 million in previous federal contracts from agencies such as the NIH, Department of Veterans Affairs, and Department of Defense to provide Simoa instruments, assays, reagents, and research services for biomarker detection research.